EnBiotix Obtains Series A Round

  • Feed Type
  • Date
    5/16/2016
  • Company Name
    EnBiotix
  • Mailing Address
    Undisclosed Cambridge, MA 98032 USA
  • Company Description
    EnBiotix is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.
  • Website
    http://www.enbiotix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Wired Holdings Investment Corp.
  • Venture Investor
    Apeiron Holdings

Trending on Xconomy

Privacy Preference Center